In this episode Dr. McNamara discusses more of the side effects of the usage of Cholesterol-Lowering Statin Drugs.
- Chapter 25: Statin Drugs May Cause Depression and Possibly Suicide
- Chapter 26: Statin Drugs Impair Memory and the Ability to Think
- Chapter 27: Statin Drugs may Cause Cancer
Chapter Excerpts
Fifteen percent of those taking statin drugs develop some cognitive side effects.
The pharmaceutical industry denies that statin drugs can cause amnesia; yet in many of their own studies, memory loss was reported.
Over 5 years, of the approximately 250 women taking Lipitor®, there were 12 new cases of breast cancers, compared to one new case among the placebo group. Certainly not proof that statin drugs cause breast cancer, but a 1500% increase risk of breast cancer is enough"smoke" to be worried about a fire.
Because Co-Q10 levels are decreased by statin drugs, it is easy to predict an increased risk of prostate and breast cancer.
Chapter References
- 43: King D, Wilburn A, Wofford M, et al. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy 2003 Dec; 23(12):1663-1667.
- 44: Muldoon M, Barger S, Ryan C, Flory J, et al. Effects of lovastatin on cognitive function and psychological well-being. Am J Med. 2000 May; 108(7):538-546.
- 45: Eleanor Laise. The Lipitor Dilemma, Smart Money: The Wall Street Journal Magazine of Personal Business, November 2003.
- 46: Duane Graveline, MD., Lipitor: Thief of Memory, 2004, www.buybooksontheweb.com.
- 47: Lopena O, Pharm D, Pfizer, Inc., written communication, 2002. Quoted in an email communication from Duane Graveline, spacedoc@webtv.net.
- 48: Leung, B, Sattar N, Crilly A, et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 2003 170:1524-1530.
- 49: Palinski, W, et al. Immunomodulation: a new role for statins? Nature Medicine, 2000 Dec 6(12):1311-1312.
- 50: Newman T, Hulley S. Carcinogenicity of lipid-lowering drugs. JAMA 1996 Jan 3; 275(1):55-60.
- 51: Folkers K, et al. Activities of Vitamin Q10 in animal models and a serious deficiency in patients with cancer. Biochem Biophys Res Commun. 1997 234(2):296-299.
- 52: Lockwood K, Moesgaard S, Yamamoto T, Folkers K. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochem Biophys Res Commun, 1995 Jul 6; 212(1):172-7.
- 53: Sacks F, Pfeffer M, Moye L, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996 Oct 3; 335(14):1001-1009.
- 54: Boudreau D, Gardner J, Malone K, et al. The association between 3-hydroxy-3-methylglutaryl co-enzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study. Cancer 2004 Jun 1; 100(11):2308-2316.
- 55: Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002 Jul 6; 360(9326):7-22.
Podcast: Play in new window | Download